During the past decade, Medizinische Fakultät Carl Gustav Carus conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Fakultät Carl Gustav Carus" #1 sponsor was "Bayer" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Technische Universität Dresden" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Fakultät Carl Gustav Carus" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Fakultät Carl Gustav Carus" are "Advanced Solid Tumor" (1 trials), "Arteriosclerosis" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Central Nervous System Diseases" (1 trials) and "Chronic Thromboembolic Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Medizinische Fakultät Carl Gustav Carus" in a lesser frequency.

Most popular intervention types in "Medizinische Fakultät Carl Gustav Carus" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-FU" (1 trials), "Atuveciclib, BAY1143572" (1 trials), "Bevacizumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Fakultät Carl Gustav Carus" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medizinische Fakultät Carl Gustav Carus". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Medizinische Fakultät Carl Gustav Carus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Fakultät Carl Gustav Carus, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".